Effects of an Web-based Support Programme for Cardiac Arrest Survivors
CARDIS
Effects of a Web-based Support Programme for Cardiac Arrest Survivors: A Randomized Controlled Trial With Process Evaluation (The CARDIS Study)
1 other identifier
interventional
120
1 country
3
Brief Summary
The overall goal of this clinical trial is to learn if a web-based support programme can improve wellbeing in cardiac arrest survivors by helping them manage emotional, cognitive, and physical challenges. The study also explores how the programme is used and experienced in practice. The main questions it aims to answer are:
- Can access to a web-based support programme improve overall wellbeing in cardiac arrest survivors?
- Can it also enhance quality of life, cognitive function, life satisfaction, and sleep, while reducing anxiety, depression, post-traumatic stress, and fatigue? Researchers will compare cardiac arrest survivors who receive a web-based support programme in addition to standard care with those who receive standard care alone, to see if the programme improves wellbeing and other health outcomes. After the study, the control group will also gain access to the programme. Participants will:
- Be asked to complete online questionnaires at three time points: at the start of the study, after 3 months, and after 6 months.
- Be encouraged to use a web-based support programme for 3 months, with unlimited access, at their own pace and according to their individual needs (intervention group only).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2025
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2025
CompletedStudy Start
First participant enrolled
November 20, 2025
CompletedFirst Posted
Study publicly available on registry
November 21, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2028
November 26, 2025
November 1, 2025
2.5 years
November 14, 2025
November 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline in Overall Wellbeing at 3 months.
The Questionnaire on Well-Being is a tool designed to capture subjective well-being. It consists of 18 questions, each rated from 0 to 4, which are added together to give a total score between 0 and 72. Higher scores reflect greater perceived well-being, while scores below 50 have been linked to significant psychological distress.
From baseline to 3 months after enrollment.
Secondary Outcomes (8)
Change from Baseline in Quality of Life at 3 and 6 months.
From baseline to 3 and 6 months after enrollment.
Change from baseline in Life Satisfaction at 3 and 6 months.
From baseline to 3 and 6 months after enrollment.
Change from baseline in Anxiety at 3 and 6 months.
From baseline to 3 and 6 months after enrollment.
Change from baseline in Depression at 3 and 6 months.
From baseline to 3 and 6 months after enrollment.
Change from baseline in Post-Traumatic Stress at 3 and 6 months.
From baseline to 3 and 6 months after enrollment.
- +3 more secondary outcomes
Study Arms (2)
Web-Based Support Programme for Cardiac Arrest Survivors
EXPERIMENTALWaitlist Control (Standard Care + Delayed Access)
NO INTERVENTIONParticipants in this arm receive standard follow-up care according to national guidelines. They do not have access to the digital support programme during the study period. However, they are placed on a waitlist and are offered access to the programme after study completion.
Interventions
The intervention consists of a web-based support programme designed for individuals recovering from cardiac arrest. Participants in the intervention group receive access to the programme for 12 weeks. The programme includes educational modules, patient and family stories, videos, practical exercises (e.g., breathing techniques, fatigue management), tools for personal recovery planning, and a moderated chat forum for peer support. Participants can access the content at their own pace and according to their individual needs. The programme is delivered entirely online and does not require any physical visits or clinical procedures.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Survival of a cardiac arrest 1 to 3 months prior to enrollment
- Access to a mobile phone, tablet, or computer with internet connection
You may not qualify if:
- Insufficient language or cognitive ability to engage with a digital intervention and complete questionnaires in Swedish
- Participation in another study involving the collection of patient-reported outcome measures (PROMs)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Dept of Cardiology
Linköping, Sweden
Dept of Cardiology
Motala, Sweden
Dept of Cardiology
Norrköping, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc professor
Study Record Dates
First Submitted
November 14, 2025
First Posted
November 21, 2025
Study Start
November 20, 2025
Primary Completion (Estimated)
May 31, 2028
Study Completion (Estimated)
August 31, 2028
Last Updated
November 26, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Beginning after completion of the blinded primary and secondary outcome analyses by the principal investigator, with no defined end date.
- Access Criteria
- Access to de-identified individual participant data (IPD) will be granted to members of the research team after completion of the blinded analysis of primary and secondary outcomes by the principal investigator. Each researcher must submit a brief description of the planned analyses and sign a data use agreement outlining responsibilities for data handling, confidentiality, and publication ethics. Access requests will be reviewed and approved by the principal investigator.
De-identified individual participant data (IPD) will be made available to members of the research team after the principal investigator has completed blinded analyses of the primary and secondary outcomes. Data will be stored securely and access will be restricted to authorized collaborators under data use agreements.